People · Operator
Named in public records as an officer, director or promoter · active 2023–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cantai Therapeutics, Inc. | — | Biotechnology | Seed | $4.3M | $6.2M | 2023 |
Ross Leimberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ross Leimberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Errik Anderson | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Errik B. Anderson | 1 | 5 |
| Getta B. Vemuri | 1 | 1 |
| Joshua Brandt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.